Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 3,724,144 shares trading hands.
Evofem Biosciences Stock Performance
The business has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01. The firm has a market capitalization of $1.13 million, a price-to-earnings ratio of -0.02 and a beta of -0.74.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Read More
- Five stocks we like better than Evofem Biosciences
- What is the Australian Securities Exchange (ASX)
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Compound Interest and Why It Matters When Investing
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Consumer Staples Stocks, Explained
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
